Infectious Disease & Vaccines

Researchers developed ingestible capsules that inject drugs into the stomach and small intestine, providing a novel oral delivery method for biologics.

Scientists have appreciated the roles of bacteria in our microbiomes for decades. Now, they’re studying the effects of the trillions of viruses that call the human body home.

Mireille Kamariza develops new chemistry-driven diagnostics for tuberculosis that can reduce the time to treatment from weeks to minutes.

Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.

For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.

Chagas disease stems from a parasitic infection. Now, with the help of a few insect-eating monkeys, a new treatment for this condition is on the horizon.

Oral vaccines stop pathogens in their tracks before they get a chance to cause disease.

Menstrual toxic shock syndrome remains a life-threatening disease, so researchers are exploring safer tampon designs, toxin neutralization, and vaccination.

Robert Georgantas aims to expand the development of mRNA-based vaccines for a range of infectious diseases and cancers.

Researchers discovered how SARS-CoV-2 invades and spreads through nasal epithelial cells, identifying potential new drug targets to prevent transmission.

Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women’s health.

As the antibiotic resistance crisis grows, scientists eye a predatory bacterium as a potential therapeutic.